These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36567243)

  • 1. Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease.
    Hacker ML; Meystedt JC; Turchan M; Cannard KR; Harper K; Fan R; Ye F; Davis TL; Konrad PE; Charles D
    Neuromodulation; 2023 Feb; 26(2):451-458. PubMed ID: 36567243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes.
    Hacker ML; Turchan M; Heusinkveld LE; Currie AD; Millan SH; Molinari AL; Konrad PE; Davis TL; Phibbs FT; Hedera P; Cannard KR; Wang L; Charles D
    Neurology; 2020 Jul; 95(4):e393-e401. PubMed ID: 32601120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early subthalamic nucleus deep brain stimulation in Parkinson's disease reduces long-term medication costs.
    Hacker M; Cannard G; Turchan M; Meystedt J; Davis T; Phibbs F; Hedera P; Konrad P; Charles D
    Clin Neurol Neurosurg; 2021 Nov; 210():106976. PubMed ID: 34666273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.
    Charles D; Konrad PE; Neimat JS; Molinari AL; Tramontana MG; Finder SG; Gill CE; Bliton MJ; Kao C; Phibbs FT; Hedera P; Salomon RM; Cannard KR; Wang L; Song Y; Davis TL
    Parkinsonism Relat Disord; 2014 Jul; 20(7):731-7. PubMed ID: 24768120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.
    Hacker ML; Currie AD; Molinari AL; Turchan M; Millan SM; Heusinkveld LE; Roach J; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Byrne DW; Charles D
    J Parkinsons Dis; 2016; 6(1):125-31. PubMed ID: 26967937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Hacker ML; DeLong MR; Turchan M; Heusinkveld LE; Ostrem JL; Molinari AL; Currie AD; Konrad PE; Davis TL; Phibbs FT; Hedera P; Cannard KR; Drye LT; Sternberg AL; Shade DM; Tonascia J; Charles D
    Neurology; 2018 Jul; 91(5):e463-e471. PubMed ID: 29959266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease.
    Hacker ML; Tramontana MG; Pazira K; Meystedt JC; Turchan M; Harper KA; Fan R; Ye F; Davis TL; Konrad PE; Charles D
    Parkinsonism Relat Disord; 2023 Aug; 113():105479. PubMed ID: 37380539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.
    Hacker ML; Tonascia J; Turchan M; Currie A; Heusinkveld L; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Wang L; Shi Y; Shade DM; Sternberg AL; Drye LT; Charles D
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1177-83. PubMed ID: 26306000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation for early-stage Parkinson's disease: an illustrative case.
    Gill CE; Allen LA; Konrad PE; Davis TL; Bliton MJ; Finder SG; Tramontana MG; Kao CC; Remple MS; Bradenham CH; Charles PD
    Neuromodulation; 2011; 14(6):515-21; discussion 521-2. PubMed ID: 21939467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.
    Vizcarra JA; Situ-Kcomt M; Artusi CA; Duker AP; Lopiano L; Okun MS; Espay AJ; Merola A
    J Neurol; 2019 Feb; 266(2):289-297. PubMed ID: 29909467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
    Kim JH; Chang WS; Jung HH; Chang JW
    Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
    Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
    J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.